Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24010830 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Qichao Ge und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shengjing Hospital of China Medical University, 36 Sanhao Street, Shenyang 110004, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors, Neoplastic Syndromes, Hereditary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, University Innovation Team and Innovative Talent Support Program of Liaoning Province, Young and Middle-Aged Science and Technology Innovation Talent Program.
Abstract (Originalsprache)
Familial gastrointestinal stromal tumor (GIST) is a rare autosomal dominant genetic disorder with only a few affected families reported to date. Here, we report a case of familial GISTs harboring a novel germline mutation within exon 18 of KIT. A 58-year-old male patient presented with gastric subepithelial lesions accompanied by cutaneous hyperpigmentation, which were subsequently diagnosed as multinodular GISTs. Endoscopic surgery was initially conducted to remove the larger lesions, and pathological examinations were then conducted for the diagnosis of GISTs. Family history revealed that some other family members had similar cutaneous pigmentations. Whole-exome sequencing was used to search for potential driver mutations, and Sanger sequencing was used for mutation validation. A novel primary driver mutation of KIT (c.G2485C, p.A829P) was detected in these hereditary GISTs, which has been reported in some targeted chemotherapy-resistant GISTs. Cell models were subsequently established for the rapid screening of candidate drugs and exploring potential mechanisms. This mutation could lead to cell proliferation and imatinib resistance by ligand-independent activation of KIT; however, ripretinib administration was identified as an applicable targeted therapy for this mutation. The mutation activated the JAK/STAT3 and MAPK/ERK pathways, which could be inhibited by ripretinib administration. To the best of our knowledge, this is the first report of the KIT-A829P mutation in familial GISTs, complementing the pathogenesis of familial GISTs and providing valuable information for the precision treatment of this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Shengjing Hospital of China Medical University, 36 Sanhao Street, Shenyang 110004, China.
- Innovative Research Center for Integrated Cancer Omics, Shengjing Hospital of China Medical University, Shenyang 110004, China.
- Innovative Engineering Technology Research Center for Cell Therapy, Shengjing Hospital of China Medical University, Shenyang 110022, China.
ORCID-Profile: Qichao Ge, Jintao Guo
Förderung
- National Natural Science Foundation of China
- University Innovation Team and Innovative Talent Support Program of Liaoning Province
- Young and Middle-Aged Science and Technology Innovation Talent Program
Zitieren
APA
Ge, Q., Liu, Y., Yang, F., Sun, G., Guo, J., & Sun, S. (2023). Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24010830
Vancouver
Ge Q, Liu Y, Yang F, Sun G, Guo J, Sun S. Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24010830
BibTeX
@article{Ge2023,
author = {Ge, Qichao and Liu, Yang and Yang, Fan and Sun, Guangwei and Guo, Jintao and Sun, Siyu},
title = {Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24010830}
}
EUVIMED